Celgene adds $30 million to investment in Soon-Shiong firm NantCell
LOS ANGELES - Drugmaker Celgene Corp. agreed to invest an additional $30 million in a cancer-fighting start-up that's majority owned by Los Angeles biotech entrepreneur Dr. Patrick…
LOS ANGELES - Drugmaker Celgene Corp. agreed to invest an additional $30 million in a cancer-fighting start-up that's majority owned by Los Angeles biotech entrepreneur Dr. Patrick…